glp-1 serotonin Interaction of serotonin/GLP-1 circuitry in a dual preclinical model for psychiatric disorders and metabolic dysfunction semaglutide and serotonin Interaction of

Novo Nordisk has sued Eli Lilly, alleging that advertisements used outdated studies to make misleading comparisons between their drugs

Renal Impairment: In patients treated with GLP-1 receptor agonists, including Saxenda , there have been reports of acute renal failure and worsening of chronic renal failure, usually in association with nausea, vomiting, diarrhea, or dehydration, which may sometimes require hemodialysis

Where public coverage is limited and self-pay remains the main route, adoption follows a clear S-curve tied to the affordability ratio (AR) the share of a consumers disposable income required for one month of therapy

Pat 29, 871879

Novo Nordisk's semaglutide beats its counterpart liraglutide to become the next generation of weight loss innovation, and then Eli Lilly's GLP-1R/GIPR dual-target agonist tirzepatide achieves a 22.5% weight loss, surpassing semaglutide's weight loss history

New work demonstrates how one antioxidant inside particular cellular compartments, the mitochondrial metabolite glutathione, helps cancer cells metastasize throughout the body by enabling their survival under low-oxygen conditions